Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype.

Penuela S, Gyenis L, Ablack A, Churko JM, Berger AC, Litchfield DW, Lewis JD, Laird DW.

J Biol Chem. 2012 Aug 17;287(34):29184-93. doi: 10.1074/jbc.M112.377176. Epub 2012 Jun 29.

2.

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.

Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M, Garbe C, Schittek B.

PLoS One. 2011;6(8):e23429. doi: 10.1371/journal.pone.0023429. Epub 2011 Aug 17.

3.

Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].

Tsai HE, Wu JC, Kung ML, Liu LF, Kuo LH, Kuo HM, Chen SC, Chan EC, Wu CS, Tai MH, Liu GS.

PLoS One. 2013;8(3):e59345. doi: 10.1371/journal.pone.0059345. Epub 2013 Mar 25. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/02369930-29de-4cd6-a059-9520af0be6b9.

4.

Estradiol differently affects melanin synthesis of malignant and normal melanocytes: a relationship with clock and clock-controlled genes.

Poletini MO, de Assis LV, Moraes MN, Castrucci AM.

Mol Cell Biochem. 2016 Oct;421(1-2):29-39. doi: 10.1007/s11010-016-2781-3. Epub 2016 Aug 18.

PMID:
27535239
5.

Tumor-suppressive effects of pannexin 1 in C6 glioma cells.

Lai CP, Bechberger JF, Thompson RJ, MacVicar BA, Bruzzone R, Naus CC.

Cancer Res. 2007 Feb 15;67(4):1545-54.

6.

TRPM1 forms ion channels associated with melanin content in melanocytes.

Oancea E, Vriens J, Brauchi S, Jun J, Splawski I, Clapham DE.

Sci Signal. 2009 May 12;2(70):ra21. doi: 10.1126/scisignal.2000146.

7.

Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.

Jung H, Chung H, Chang SE, Choi S, Han IO, Kang DH, Oh ES.

Pigment Cell Melanoma Res. 2014 May;27(3):387-97. doi: 10.1111/pcmr.12223. Epub 2014 Feb 25.

PMID:
24472179
8.

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA.

Cancer Res. 1994 Apr 1;54(7):1766-71.

9.

Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.

Rad HH, Yamashita T, Jin HY, Hirosaki K, Wakamatsu K, Ito S, Jimbow K.

Exp Cell Res. 2004 Aug 15;298(2):317-28. Erratum in: Exp Cell Res. 2004 Dec 10;301(2):338.

PMID:
15265682
10.

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.

Avery-Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, Talseth-Palmer BA, Rizos H, Zhang XD, Scott RJ, Hersey P.

BMC Cancer. 2011 May 27;11:203. doi: 10.1186/1471-2407-11-203.

11.

Syndecan-2 regulates the migratory potential of melanoma cells.

Lee JH, Park H, Chung H, Choi S, Kim Y, Yoo H, Kim TY, Hann HJ, Seong I, Kim J, Kang KG, Han IO, Oh ES.

J Biol Chem. 2009 Oct 2;284(40):27167-75. doi: 10.1074/jbc.M109.034678. Epub 2009 Jul 29.

12.

Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.

Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G.

Melanoma Res. 2007 Oct;17(5):265-73.

PMID:
17885581
13.

Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE.

Lai SS, Xue B, Yang Y, Zhao L, Chu CS, Hao JY, Wen CJ.

Cancer Genet. 2012 Nov;205(11):552-62. doi: 10.1016/j.cancergen.2012.09.002. Epub 2012 Nov 9.

PMID:
23142633
14.

Desensitization of melanoma cells to autocrine TGF-beta isoforms.

Krasagakis K, Krüger-Krasagakes S, Fimmel S, Eberle J, Thölke D, von der Ohe M, Mansmann U, Orfanos CE.

J Cell Physiol. 1999 Feb;178(2):179-87.

PMID:
10048582
15.

The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.

Cao J, Dai X, Wan L, Wang H, Zhang J, Goff PS, Sviderskaya EV, Xuan Z, Xu Z, Xu X, Hinds P, Flaherty KT, Faller DV, Goding CR, Wang Y, Wei W, Cui R.

Sci Signal. 2015 Sep 1;8(392):ra87. doi: 10.1126/scisignal.aab1995.

PMID:
26329581
16.

Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.

Eberle J, Garbe C, Kroumpouzos G, Orfanos CE.

Recent Results Cancer Res. 1995;139:123-35.

PMID:
7597285
17.

Expression patterns of S100 proteins in melanocytes and melanocytic lesions.

Petersson S, Shubbar E, Enerbäck L, Enerbäck C.

Melanoma Res. 2009 Aug;19(4):215-25. doi: 10.1097/CMR.0b013e32832c6358.

PMID:
19521263
18.

Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A.

Genes Dev. 2002 Aug 15;16(16):2058-72.

19.

Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.

Selzer E, Okamoto I, Lucas T, Kodym R, Pehamberger H, Jansen B.

Melanoma Res. 2002 Jun;12(3):201-9.

PMID:
12140376
20.

Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.

Wehbe M, Soudja SM, Mas A, Chasson L, Guinamard R, de Tenbossche CP, Verdeil G, Van den Eynde B, Schmitt-Verhulst AM.

PLoS One. 2012;7(11):e49419. doi: 10.1371/journal.pone.0049419. Epub 2012 Nov 16.

Supplemental Content

Support Center